Old Web
English
Sign In
Acemap
>
Paper
>
Out of Specification Tisagenlecleucel Does Not Compromise Safety or Efficacy in Pediatric Acute Lymphoblastic Leukemia.
Out of Specification Tisagenlecleucel Does Not Compromise Safety or Efficacy in Pediatric Acute Lymphoblastic Leukemia.
2021
Jenna Rossoff
Christina Baggott
Snehit Prabhu
Holly L Pacenta
Christine L. Phillips
Heather E Stefanski
Julie-An Talano
Amy Moskop
Steven P. Margossian
Michael R. Verneris
G. Doug Myers
Nicole Karras
Patrick A Brown
Muna Qayed
Michelle L. Hermiston
Prakash Satwani
Christa Krupski
Amy K. Keating
Rachel Wilcox
Cara A Rabik
Vanessa A. Fabrizio
Michael Kunicki
Vasant Chinnabhandar
A Yasemin Goksenin
Kevin J. Curran
Crystal L. Mackall
Theodore W. Laetsch
Liora Schultz
Keywords:
Pediatric Acute Lymphoblastic Leukemia
MEDLINE
Pediatrics
Compromise
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
6
References
0
Citations
NaN
KQI
[]